title: Gene therapy, an ongoing revolution.
abstract: In this issue of Blood, Buchlis and colleagues describe the long-term persistence (up to 10 years) of factor IX (FIX) expression in adeno-associated virus serotype 2 (AAV-2)–injected muscles of a patient with hemophilia B.
authors.affiliation: Université Pierre et Marie Curie.
authors.forename: Olivier
authors.initials: O
authors.lastname: Benveniste
mesh_terms: D000229:Dependovirus / Q000235:genetics*; D005164:Factor IX / Q000235:genetics*; D015316:Genetic Therapy / Q000379:methods*; D002836:Hemophilia B / Q000628:therapy*; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism*
chemical_list: D005164:Factor IX